2007 Press Releases

Allergan Announces New Board Member; Dawn Hudson Appointed  

Allergan, Inc. and Covidien Ltd. Enter into Co-Promotion Agreement for LAP-BAND(R) Adjustable Gastric Banding System  

Allergan Reports Third Quarter Operating Results  

Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%  

Allergan Announces Completion of Esprit Pharma Acquisition  

Allergan Announces Quarterly Conference Call  

Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.  

Allergan, Inc. (NYSE:AGN) today announced operating results for the quarter ended June 29, 2007. Allergan also announced that its Board of Directors...  

Allergan Announces Quarterly Conference Call  

Allergan Announces FDA Approval of Label Extensions for JUVEDERM(TM) Ultra and JUVEDERM(TM) Ultra Plus  

Oscar(R)-Nominated Actress Virginia Madsen Announces Launch of Keep the Wisdom. Lose the Lines.(TM) Health Education Campaign with Allergan, Inc.  

Allergan Reports First Quarter Operating Results  

U.S. Federal Circuit Court Affirms Judgment for Allergan, Inc. and Roche Palo Alto, LLC against Apotex, Inc., Apotex Corp., and Novex Pharma in Ketorolac Patent Infringement Lawsuit  

Allergan Announces Quarterly Conference Call  

Allergan Announces Its Acquisition of EndoArt, a Leading Swiss Developer of Remote-Controlled Medical Devices  

Allergan Reports Fourth Quarter Operating Results  

Allergan, Inc. Announces Nationwide Availability of JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS Dermal Fillers  

Allergan Announces Quarterly Conference Call